Risk of venous thromboembolism among hospitalized medically ill patients

被引:47
|
作者
Edelsberg, John [1 ]
Hagiwara, May [1 ]
Taneja, Charu [1 ]
Oster, Gerry [1 ]
机构
[1] Policy Anal Inc, Brookline, MA 02445 USA
关键词
heart failure; hospitals; neoplasms; peripheral vascular diseases; surgery; thromboembolism;
D O I
10.2146/ajhp060389
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The 90-day risk of venous thromboembolism (VTE) among medically ill patients admitted to a hospital was estimated and is discussed. Summary. Patients aged >= 40 years who were hospitalized between January 1, 1998, and June 30, 2002, for reasons other than traumatic injury, labor and delivery, mental disorder, or VTE and who did not undergo surgery were identified in a large U.S. healthcare claims database. Patients receiving anticoagulants in the 90-day period preceding hospital admission were excluded. We estimated the percentage of study subjects who developed clinical deep-vein thrombosis (DVT) or pulmonary embolism (PE) within 90 days of hospital admission using Kaplan-Meier methods. We also estimated hazard ratios (HRs) for potential risk factors for VTE using univariate and stepwise multivariate Cox proportional hazards regression models. Among 92,162 study subjects, 1468 (1.59%) developed clinical DVT or PE within 90 days of hospital admission; 18% of these events occurred postdischarge. In multivariate analyses, significant risk factors for clinical VTE included: 1) history of cancer (HR, 1.67; 95% confidence interval [CI], 1.45-1.93); 2) history of VTE within six months of index admission (HR, 6.14: 95% Cl, 4.74-7.96); 3) operating room procedure within 30 clays of index admission (HR, 1.81; 95% Cl, 1.47-2.24); 4) peripheral artery disease during index admission (HR, 1.68;95% CI, 1.28-2.21);and 5) heart failure during index admission (HR, 1.72; 95% Cl, 1.52-1.95). Conclusion. The risk of clinical VTE among medically ill patients admitted to a hospital, although less than that of patients undergoing major surgery, is not negligible. Patients with a history of recent VTE or surgery, those who are admitted to the intensive care unit, those with an admitting diagnosis of heart failure, and those with active cancer are at especially high risk of VTE and deserve increased consideration for prophylaxis.
引用
收藏
页码:S16 / S22
页数:7
相关论文
共 50 条
  • [1] Cost of venous thromboembolism in hospitalized medically ill patients
    Pendergraft, Trudy
    Atwood, Mark
    Liu, Xianchen
    Phatak, Hemant
    Liu, Larry Z.
    Oster, Gerry
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (19) : 1681 - 1687
  • [2] Cost of venous thromboembolism in hospitalized medically ill patients
    Pendergraft, T.
    Atwood, M.
    Liu, X.
    Phatak, H.
    Liu, L.
    Oster, G.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 294 - 295
  • [3] Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients
    Amin, Alpesh N.
    Varker, Helen
    Princic, Nicole
    Lin, Jay
    Thompson, Stephen
    Johnston, Stephen
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2012, 7 (03) : 231 - 238
  • [4] Prophylaxis Against Venous Thromboembolism in Hospitalized Medically Ill Patients
    Pendergraft, Trudy
    Liu, Xianchen
    Edelsberg, John
    Phatak, Hemant
    Vera-Llonch, Montserrat
    Liu, Larry Z.
    Oster, Gerry
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (01): : 75 - 82
  • [5] Thromboprophylaxis in medically ill patients at risk for venous thromboembolism
    Burleigh, Edward
    Wang, Cheng
    Foster, David
    Heller, Sivana
    Dunn, Dennis
    Safavi, Kaveh
    Griffin, Brian
    Smith, Jeff
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S23 - S29
  • [6] VENOUS THROMBOEMBOLISM PROPHYLAXIS AND CLINICAL CONSEQUENCES IN HOSPITALIZED MEDICALLY ILL PATIENTS
    Baser, O.
    Liu, X.
    Phatak, H.
    Wang, L.
    Mardekian, J.
    Kawabata, H.
    Petersel, D.
    Hamilton, M.
    Ramacciotti, E.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A115 - A115
  • [7] Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A US Perspective
    Spyropoulos, Alex C.
    Ageno, Walter
    Cohen, Alexander T.
    Gibson, C. Michael
    Goldhaber, Samuel Z.
    Raskob, Gary
    [J]. THROMBOSIS AND HAEMOSTASIS, 2020, 120 (06) : 924 - 936
  • [8] Prophylaxis against venous thromboembolism in hospitalized medically ill patients: Update and practical approach
    Camden, Ryan
    Ludwig, Shannon
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (11) : 909 - 917
  • [9] Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial
    Kalayci, Arzu
    Gibson, C. Michael
    Hernandez, Adrian F.
    Hull, Russell D.
    Cohen, Alexander T.
    Fitzgerald, Clara
    Hussain, Syed D.
    Chi, Gerald
    Alkhalfan, Fahad
    Harrington, Robert A.
    Goldhaber, Samuel Z.
    [J]. THROMBOSIS RESEARCH, 2022, 211 : 63 - 69
  • [10] Betrixaban in the prevention of venous thromboembolism in medically ill patients
    Sylvester, Katelyn W.
    Connors, Jean M.
    [J]. FUTURE CARDIOLOGY, 2018, 14 (06) : 455 - 470